Daré Bioscience, Inc. DARE
Set alert
At close · Oct 30
After hours · Oct 30, 7:24 PM ET
- YTD
- -63.75%
- 1 year
- -63.75%
- Open
- 0.7026
- Prev close
- 0.6815
- Mkt cap
- 13.76M
- Vol
- 654.01K
- Avg vol
- 496.64K
- EPS
- -0.71
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.67
- High
- 0.7026
- Forward P/E
- -2.35
- Beta
- 1.34
- Short ratio
- 0.64
- Inst. own
- 7.59%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.53
- 200-d avg
- 4.07
- 1y target
- 21.33
5D chart
Signals (126)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 29, 1:35 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:50 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:35 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 12:35 PM | 3 days ago |
| RSI: Overbought | Oct 29, 12:35 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:10 PM | 3 days ago |
| SMA: Bearish | Oct 29, 11:50 AM | 3 days ago |
| RSI: Overbought | Oct 29, 11:10 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:30 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:30 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 10:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:00 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 9:55 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 9:45 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:20 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:20 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:15 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:15 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 3 days ago |
| RSI: Oversold | Oct 28, 3:10 PM | 3 days ago |
| RSI: Overbought | Oct 28, 2:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:35 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 2:35 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:10 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:05 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 1:05 PM | 4 days ago |
| RSI: Overbought | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:05 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:05 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:05 PM | 4 days ago |
| RSI: Overbought | Oct 28, 12:05 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:40 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:20 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:15 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:40 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:25 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:10 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 27, 3:40 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:40 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:30 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:30 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:20 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:00 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 2:50 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:40 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:30 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:15 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:15 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:10 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:10 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:45 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:45 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 1:45 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:30 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:20 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:20 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:15 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:15 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 11:55 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:25 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:05 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:05 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:05 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:00 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:50 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:40 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:35 AM | 5 days ago |
| RSI: Overbought | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:40 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:30 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:50 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:50 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 1:50 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 1:40 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:35 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:35 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:00 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:00 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:30 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 12:15 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:10 PM | 6 days ago |
| SMA: Bullish | Oct 26, 11:50 AM | 6 days ago |
| SMA: Bearish | Oct 26, 11:40 AM | 6 days ago |
| SMA: Bullish | Oct 26, 10:55 AM | 6 days ago |
| MACD: Buy Signal | Oct 26, 10:25 AM | 6 days ago |
| SMA: Bullish | Oct 26, 10:20 AM | 6 days ago |
| SMA: Bearish | Oct 26, 9:35 AM | 6 days ago |
| SMA: Bearish | Oct 26, 9:35 AM | 6 days ago |
| SMA: Bullish | Oct 26, 9:30 AM | 6 days ago |
| SMA: Bullish | Oct 26, 9:30 AM | 6 days ago |
| SMA: Bearish | Oct 23, 3:55 PM | 1 week ago |
| SMA: Bearish | Oct 23, 3:55 PM | 1 week ago |
| SMA: Bullish | Oct 23, 3:50 PM | 1 week ago |
| SMA: Bullish | Oct 23, 3:50 PM | 1 week ago |
| SMA: Bearish | Oct 23, 3:45 PM | 1 week ago |
| SMA: Bullish | Oct 23, 3:00 PM | 1 week ago |
| SMA: Bearish | Oct 23, 3:00 PM | 1 week ago |
| SMA: Bullish | Oct 23, 2:40 PM | 1 week ago |
| SMA: Bearish | Oct 23, 2:25 PM | 1 week ago |
| SMA: Bearish | Oct 23, 2:25 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 2:25 PM | 1 week ago |
| MACD: Buy Signal | Oct 23, 2:20 PM | 1 week ago |
| SMA: Bullish | Oct 23, 2:10 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 2:00 PM | 1 week ago |
| SMA: Bearish | Oct 23, 1:50 PM | 1 week ago |
| SMA: Bullish | Oct 23, 1:15 PM | 1 week ago |
| MACD: Buy Signal | Oct 23, 1:15 PM | 1 week ago |
| RSI: Overbought | Oct 23, 1:15 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 1:10 PM | 1 week ago |
| SMA: Bearish | Oct 23, 12:45 PM | 1 week ago |
| SMA: Bullish | Oct 23, 12:40 PM | 1 week ago |
| RSI: Overbought | Oct 23, 12:40 PM | 1 week ago |
| SMA: Bearish | Oct 23, 12:30 PM | 1 week ago |
| SMA: Bullish | Oct 23, 10:55 AM | 1 week ago |
| SMA: Bearish | Oct 23, 10:20 AM | 1 week ago |
News
-
2 days ago benzinga.com
Daré Bioscience Receive Additional $1.5M Funding Installment Under Grant Agreement For DARE-LARC1
With this installment, Daré Bioscience has received a total of approximately $43.3 million in non-dilutive funding under the grant agreement. The remaining approximately $5.6 million of the up to…
2 days ago globenewswire.com
Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum
Latest $1.5 Million Installment Reflects Continued Milestone Progress as DARE-LARC1 Advances in Preclinical Development
4 days ago globenewswire.com
Daré Bioscience Addresses New National Focus on Women's Health in Virtual Investor “What This Means” Discussion
Sabrina Martucci Johnson, President and CEO, shares her perspective on the recent White House Executive Order and how Daré Bioscience's growing commercial portfolio and clinical pipeline position the…
6 days ago globenewswire.com
Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly
A single device designed to replace months to years of repeat injections, with potential applications well beyond its lead contraception program
1 week ago globenewswire.com
Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer
Premier sponsorship of the HERmedicine and OncoMenopause Consortium® program underscores Daré Bioscience's commitment to addressing unmet women's health needs, including for women affected by breast…
2 weeks ago globenewswire.com
Daré Bioscience Launches “CEO Corner” Video Series to Highlight the Company's Pipeline of Women's Health Innovations, Corporate Strategy and Opportunities
New video series featuring Founder, President and CEO Sabrina Martucci Johnson will provide investors with insights into Daré Bioscience's growing commercial portfolio, clinical pipeline and…
2 weeks ago defenseworld.net
Contrasting RYTHM (NASDAQ:RYM) & Dare Bioscience (NASDAQ:DARE)
Dare Bioscience (NASDAQ: DARE - Get Free Report) and RYTHM (NASDAQ: RYM - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two…
2 weeks ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Biomea Fusion (NASDAQ:BMEA) stock increased by 11.0% to $1.51 during Monday's after-market session. The market value of their outstanding shares is at $102.9 million. iTonic Holdings…
-
3 weeks ago benzinga.com
Daré Bioscience To Present Clinical Data From A Phase 1 Study Evaluating Sildenafil Cream, 3.6% Investigational Product At The Sexual Medicine Society Of North America Meeting, October 8-11
linical data from a Phase 1 study that evaluated the Company’s proprietary Sildenafil Cream, 3.6% investigational product (Sildenafil Cream) will be presented at the Annual Fall Scientific Meeting of…
-
1 month ago benzinga.com
Daré Bioscience Receives U.S. Patent For Its Pharmaceutical Compositions Formulated For Topical Application Comprising Lopinavir, Ritonavir To Treat Cervical Pathologies
Daré Bioscience, Inc. (NASDAQ:DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced…
1 month ago globenewswire.com
Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
New U.S. patent expands intellectual property foundation for DARE-HPV, a potential first-in-category treatment targeting persistent high-risk HPV infection
-
1 month ago benzinga.com
Daré Bioscience Announces Publication Of Results From A Phase 1 Clinical Study Evaluating Safety And Systemic Pharmacokinetics Of Topical Sildenafil Cream, 3.6%, In Healthy Adult Men In The Journal Sexual Medicine; At 71 Mg Topical Dose, Mean Maximum Plasma Concentration Of Sildenafil Was ~187-Fold Lower Than Following A 50 Mg Oral Dose
The article, titled, "An open-label, single-dose, randomized, parallel-group study of the safety and relative bioavailability of topical sildenafil cream vs oral sildenafil in healthy male adults,"…
1 month ago globenewswire.com
Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil
Published Phase 1 data in Sexual Medicine strengthen the scientific foundation for Daré Bioscience's proprietary topical Sildenafil Cream, 3.6%
1 month ago globenewswire.com
Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand
View the video webcast here
1 month ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers EXoZymes (NASDAQ:EXOZ) stock increased by 7.5% to $7.18 during Wednesday's after-market session. The market value of their outstanding shares is at $58.5 million. AEON Biopharma (AMEX:AEON)…
2 months ago globenewswire.com
Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth
New NIH award will provide approximately $908,000 in year-long support of preclinical development, with potential for an additional future-year grant of approximately $1.3 million
2 months ago globenewswire.com
Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series
Video webcast now available here
2 months ago seekingalpha.com
Daré Bioscience, Inc. (DARE) Discusses Women's Health Portfolio and Commercial Launches During Virtual Bus Tour Transcript
Daré Bioscience, Inc. (DARE) Discusses Women's Health Portfolio and Commercial Launches During Virtual Bus Tour Transcript
-
2 months ago benzinga.com
Daré Bioscience Announces Publication Of Clinical Study Results From Its Proprietary Formulation Of Topical Sildenafil Cream, 3.6%, In Menopause In The Journal Of The Menopause Society; 3.6% Was Well Tolerated Across All Evaluated Doses In The Clinical Study, With Minimal Systemic Exposure
The peer-reviewed article, titled, "A phase 1, open-label, within-participant dose-escalation study to evaluate the safety and pharmacokinetics of topical sildenafil cream in healthy postmenopausal…
2 months ago globenewswire.com
Daré Bioscience's Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society
Daré's proprietary formulation of topical sildenafil cream, 3.6% was well tolerated across all evaluated doses in the clinical study, with minimal systemic exposure Company continues activities…
2 months ago globenewswire.com
Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment
President & CEO, Sabrina Martucci Johnson, discusses the Company's shift to commercial stage, upcoming revenue opportunities, Ovaprene's positive interim Phase 3 results and what could drive value…
2 months ago globenewswire.com
DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List
National recognition comes as Daré Bioscience advances a multi-product women's health strategy across commercialization, clinical development and first-in-category innovation National recognition…
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular session. The company's market cap stands at $23.7 million. The company's, Q2 earnings came out yesterday.
2 months ago globenewswire.com
Daré Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SAN DIEGO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (Nasdaq: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising…
2 months ago seekingalpha.com
Daré Bioscience, Inc. (DARE) Q2 2026 Earnings Call Transcript
Daré Bioscience, Inc. (DARE) Q2 2026 Earnings Call Transcript
2 months ago zacks.com
Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Beats Revenue Estimates
Dare Bioscience, Inc. (DARE) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to a loss of $0.45 per share a year ago.
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Akanda (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session. The company's market cap stands at $2.9 million. Capricor Therapeutics (NASDAQ:CAPR) stock moved…
2 months ago globenewswire.com
Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women's Health Strategy Advances
Company launches Flora Sync LF5™, the company's first directly commercialized product, began generating revenue in July
2 months ago seekingalpha.com
Daré Bioscience, Inc. (DARE) Discusses Portfolio Advancements and Therapeutic Solutions for Women's Health Transcript
Daré Bioscience, Inc. (DARE) Discusses Portfolio Advancements and Therapeutic Solutions for Women's Health Transcript
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's regular session. The company's market cap stands at $33.0 million. Advanced Biomed (NASDAQ:ADVB) stock…
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
6 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
7 months ago benzinga.com
Earnings Scheduled For March 26, 2026
Earnings Scheduled For March 26, 2026
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
11 months ago benzinga.com
Earnings Scheduled For November 13, 2025
Earnings Scheduled For November 13, 2025
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
1 year ago benzinga.com
Earnings Scheduled For August 14, 2025
Earnings Scheduled For August 14, 2025
1 year ago benzinga.com
Crude Oil Moves Lower; Daré Bioscience Shares Jump
Crude Oil Moves Lower; Daré Bioscience Shares Jump
1 year ago benzinga.com
US Stocks Edge Lower; Fastenal Posts Upbeat Earnings
US Stocks Edge Lower; Fastenal Posts Upbeat Earnings
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
1 year ago benzinga.com
Earnings Scheduled For November 14, 2024
Earnings Scheduled For November 14, 2024
-
2 years ago benzinga.com
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session